Can GLP-1s Cause Long-Term Side Effects Rare but serious long-term complications of GLP-1 medications include gallbladder disease, and eye problems caused by rapid drops in blood sugar. Weight loss on GLP-1s also causes muscle and bone density loss, increasing fracture and frailty risk. Long-term benefits include reduced risk of heart attacks, strokes, chronic kidney disease progression, and liver complications. GLP-1 drugs, including Ozempic, Wegovy, Mounjaro, and others, are widely used to treat type 2 diabetes and manage weight in people with obesity. Their effectiveness has made them increasingly popular, but people using these medications may have questions about their long-term side effects and safety. Source: Jayhoo, 9/24/2026GLP-1 약물이 장기적인 부작용을 유발할 수 있을까요?

Rare but serious long-term complications of GLP-1 medications include gallbladder disease, and eye problems caused by rapid drops in blood sugar.
Weight loss on GLP-1s also causes muscle and bone density loss, increasing fracture and frailty risk.
Long-term benefits include reduced risk of heart attacks, strokes, chronic kidney disease progression, and liver complications.

GLP-1 drugs, including Ozempic, Wegovy, Mounjaro, and others, are widely used to treat type 2 diabetes and manage weight in people with obesity.

Their effectiveness has made them increasingly popular, but people using these medications may have questions about their long-term side effects and safety.Source: Jayhoo,

9/24/2026

GLP-1 약물이 장기적인 부작용을 유발할 수 있을까요?

GLP-1 약물로 인한 드물지만 심각한 장기적 합병증으로는 담낭 질환과 급격한 혈당 저하로 인한 안구 문제가 있습니다.
또한 GLP-1 약물 사용에 따른 체중 감량은 근육량 및 골밀도 감소를 초래하여 골절 및 쇠약 위험을 높일 수 있습니다.
반면 장기적인 이점으로는 심장마비, 뇌졸중, 만성 신장 질환의 진행 및 간 관련 합병증의 위험 감소 등이 있습니다.

오젬픽(Ozempic), 위고비(Wegovy), 마운자로(Mounjaro) 등을 포함한 GLP-1 약물은 제2형 당뇨병 치료 및 비만 환자의 체중 관리에 널리 사용되고 있습니다.

이러한 약물은 뛰어난 효과로 인해 인기가 높아지고 있지만, 사용자들은 장기적인 부작용이나 안전성에 대해 궁금해할 수 있습니다.

출처: Jayhoo,

2026년 9월 24일